Effects of noradrenaline on neuronal NOS2 expression and viability.

The authors previously showed that conditioned media (CM) from activated microglia increased inducible nitric oxide synthase (NOS2) in cortical neurons. Here they examined the ability of noradrenaline (NA) to reduce neuronal NOS2 or cell death. Primary mouse cortical neurons were activated using CM from microglia incubated with lipopolysaccharide (LPS). Neuronal NOS2 was assessed by increases in nitrite accumulation, and increases in NOS2 mRNA levels and fluorescence of the NO-sensitive probe DAF-2 DA. NOS2 induction was associated with an increase in neuronal LDH release. When NA was added during microglial activation, neuronal NOS2 was significantly reduced (by approximately 70%); in contrast if NA was added to the neurons along with CM, there was less reduction (about 35% decrease) in NOS2 expression. NA added to either microglia or to neurons reduced neuronal LDH release comparably. Pretreatment of CM with blocking antibody to TNFalpha, alone or with IL1-receptor antagonist, partially reduced neuronal cell death and NOS2. Incubation of neurons with NA increased IkBalpha, which could reduce NOS2. These results demonstrate that NA modulates neuronal NOS2 expression and damage, and that these effects are primarily due to inhibition of microglia released factors. Perturbations of NA could exacerbate neuronal damage by allowing for increased inflammatory responses.

[1]  D. Feinstein,et al.  Norepinephrine protects cortical neurons against microglial‐induced cell death , 2005, Journal of neuroscience research.

[2]  A. Floden,et al.  β-Amyloid-Stimulated Microglia Induce Neuron Death via Synergistic Stimulation of Tumor Necrosis Factor α and NMDA Receptors , 2005, The Journal of Neuroscience.

[3]  K. Triantafilou,et al.  The dynamics of LPS recognition: complex orchestration of multiple receptors , 2005 .

[4]  P. Spano,et al.  Inhibition of IκBα phosphorylation prevents glutamate-induced NF-κB activation and neuronal cell death , 2005 .

[5]  K. Breen,et al.  Inducible form of nitric oxide synthase expression in rat cortical neuronal cells in vitro , 2004, Neurobiology of Disease.

[6]  D. Feinstein,et al.  Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1β production , 2004, Journal of Neuroinflammation.

[7]  A. Rosenquist,et al.  Noradrenergic mechanisms in neurodegenerative diseases: a theory , 2004, Brain Research Reviews.

[8]  D. Feinstein,et al.  Intrinsic Regulation of Brain Inflammatory Responses , 2003, Cellular and Molecular Neurobiology.

[9]  M. Schwaninger,et al.  Glutamate activates NF‐κB through calpain in neurons , 2003 .

[10]  Pamela L. Follett,et al.  Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Leza,et al.  Induction of Cyclooxygenase-2 Accounts for Restraint Stress-Induced Oxidative Status in Rat Brain , 2003, Neuropsychopharmacology.

[12]  D. Feinstein,et al.  Noradrenergic depletion increases inflammatory responses in brain: effects on IκB and HSP70 expression , 2003, Journal of neurochemistry.

[13]  S. Barger,et al.  Neuronal kappa B-binding factors consist of Sp1-related proteins. Functional implications for autoregulation of N-methyl-D-aspartate receptor-1 expression. , 2002, The Journal of biological chemistry.

[14]  D. Feinstein,et al.  Noradrenergic regulation of inflammatory gene expression in brain , 2002, Neurochemistry International.

[15]  D. Feinstein,et al.  Norepinephrine Increases IκBα Expression in Astrocytes* , 2002, The Journal of Biological Chemistry.

[16]  G. Scambia,et al.  Erythropoietin exerts anti‐apoptotic effects on rat microglial cells in vitro , 2002, The European journal of neuroscience.

[17]  L. Acarín,et al.  Expression of inducible nitric oxide synthase and cyclooxygenase‐2 after excitotoxic damage to the immature rat brain , 2002, Journal of neuroscience research.

[18]  T. Klockgether,et al.  Noradrenergic Depletion Potentiates β-Amyloid-Induced Cortical Inflammation: Implications for Alzheimer's Disease , 2002, The Journal of Neuroscience.

[19]  T. Klockgether,et al.  Neuronal and Glial Coexpression of Argininosuccinate Synthetase and Inducible Nitric Oxide Synthase in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[20]  D. Feinstein,et al.  Expression and function of inducible nitric oxide synthase in neurons , 2001, Journal of Neuroimmunology.

[21]  S. Oyadomari,et al.  Coinduction of inducible nitric oxide synthase and arginine recycling enzymes in cytokine-stimulated PC12 cells and high output production of nitric oxide. , 2000, Brain research. Molecular brain research.

[22]  T. Klockgether,et al.  Peroxisome Proliferator-Activated Receptor-γ Ligands Reduce Neuronal Inducible Nitric Oxide Synthase Expression and Cell DeathIn Vivo , 2000, The Journal of Neuroscience.

[23]  W. Klaus,et al.  Simultaneous measurement of intracellular Ca(2+) and nitric oxide: a new method. , 2000, Cell calcium.

[24]  T. Klockgether,et al.  Temporal, regional, and cell-specific changes of iNOS expression after intrastriatal microinjection of interferon gamma and bacterial lipopolysaccharide , 2000, Journal of Chemical Neuroanatomy.

[25]  T. Klockgether,et al.  Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase , 1999, Journal of Neuroimmunology.

[26]  N. Bazan,et al.  Interleukin‐1 beta activates expression of cyclooxygenase‐2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet‐activating factor as a preferential mediator of cyclooxygenase‐2 expression , 1999, Journal of neuroscience research.

[27]  D. Dickson,et al.  Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques. , 1999, Journal of neuropathology and experimental neurology.

[28]  J. Leza,et al.  Neuronal death induced by SIN-1 in the presence of superoxide dismutase: protection by cyclic GMP , 1998, Neuropharmacology.

[29]  M. Weller,et al.  Induction of Nitric Oxide Synthase and Nitric Oxide‐Mediated Apoptosis in Neuronal PC12 Cells After Stimulation with Tumor Necrosis FActor‐α/Lipopolysaccharide , 1998 .

[30]  M. Sporn,et al.  Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease , 1996, The Journal of experimental medicine.

[31]  G. Yadid,et al.  In Vivo Expression of Inducible Nitric Oxide Synthase in Cerebellar Neurons , 1996, Journal of neurochemistry.

[32]  P. Baeuerle,et al.  Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Guerrini,et al.  Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Murota,et al.  Induction of calcium-independent nitric oxide synthase activity in cultured cerebellar granule neurons , 1995, Neuroscience Letters.

[35]  G. Levi,et al.  Glutamate production by cultured microglia: differences between rat and mouse, enhancement by lipopolysaccharide and lack effect of HIV coat protein gp120 and depolarizing agents , 1994, Neuroscience Letters.

[36]  J. P. Schwartz,et al.  Expression of inducible nitric oxide synthase by neurones following exposure to endotoxin and cytokine , 1994, British journal of pharmacology.

[37]  D. Mann.  The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system , 1983, Mechanisms of Ageing and Development.

[38]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.